two
seri
acid
deriv
hydroxyethylen
ethyliden
linker
synthes
evalu
antiprolif
activ
seven
malign
tumor
cell
line
antivir
activ
broad
rang
virus
conform
unrestrict
spacer
lacton
unit
seri
profound
effect
antitumor
activ
besid
introduct
long
side
chain
led
synthesi
decylsubstitut
acid
account
select
potent
antiprolif
activ
breast
cancer
cell
cell
nm
rang
analysi
show
compound
strongli
enhanc
express
hypoxia
induc
transcript
factor
extent
decreas
express
nitric
oxid
synthas
suggest
role
regul
signal
pathway
pmethoxyphenylsubstitut
deriv
display
specif
anticytomegaloviru
cmv
potenti
wherea
aliphaticsubstitut
deriv
potent
yet
rel
nonspecif
antivaricellazost
vzv
activ
even
though
lascorb
acid
lasa
cancer
therapi
controversi
histori
interest
lasa
renew
due
recent
demonstr
abil
select
kill
cancer
cell
shown
lasa
inhibit
growth
kra
braf
mutant
colorect
cancer
cell
caus
oxid
stress
accumul
reactiv
oxygen
speci
ro
latter
lead
inactiv
glyceraldehyd
dehydrogenas
gapdh
energi
crisi
consequ
cell
death
lascorb
acid
establish
activ
nonhem
iron
aketoglutar
akg
dioxygenas
hypoxia
induc
factor
prolyl
hydroxylas
hif
phd
epigenet
teneleven
transloc
tet
enzym
directli
relev
cancer
suscept
progress
critic
mediat
cellular
respons
hypoxia
make
attract
molecular
target
anticanc
therapi
hydroxyl
prolin
normoxia
tag
subsequ
ubiquitinyl
proteasom
degrad
activ
enzym
hif
prolyl
hydroxylas
inhibit
hiftrigg
antihypox
program
latter
adapt
respons
malign
tumor
hypox
stress
activ
recent
observ
lascorb
acid
deriv
promot
tumor
cell
death
furthermor
recent
progress
epigenet
identifi
new
role
ascorb
regul
demethyl
deoxyribonucl
acid
dna
histon
protein
found
lasa
act
direct
regul
tet
activ
dna
methyl
mous
embryon
stem
es
cell
thu
indic
potenti
applic
treat
cancer
driven
aberr
dna
methyl
clinic
lascorb
also
show
select
kill
effect
variou
human
breast
cancer
cell
line
depend
sodiumvitamin
c
transport
express
respons
lascorb
uptak
imidazol
lasa
deriv
exert
pronounc
cytostat
effect
human
tcell
acut
lymphoblast
leukemia
cell
moreov
pyrimidin
purin
deriv
acid
acid
deriv
show
antiprolif
effect
panel
tumor
cell
antivir
potenc
vzv
cmv
fig
observ
odibenzyllascorb
acid
deriv
exhibit
better
growth
inhibit
malign
tumor
cell
antivir
activ
analogu
found
increas
applic
drug
discoveri
recogn
good
amid
bioisoster
readili
associ
biolog
target
hydrogen
bond
interact
accordingli
seri
molecul
contain
pentacycl
triterpen
moieti
connect
lasa
via
shown
exhibit
antiinfluenza
viru
activ
show
odibenzyl
lasa
skeleton
crucial
antivir
potenc
regardless
triterpen
fragment
addit
sever
aspulvinon
compound
contain
gbutenolid
moieti
show
signific
antiinfluenza
viru
activ
mind
effect
potenti
synergi
antitumor
antivir
activ
lasa
moieti
design
synthes
lascorb
acid
deriv
unsatur
analogu
core
atom
hypothes
new
chemic
entiti
might
exhibit
pronounc
select
antitumor
andor
antivir
activ
investig
influenc
substitu
conjug
lasa
biolog
activ
straight
branch
alkyl
chain
differ
length
cyclopropyl
various
substitut
aromat
benzenesulfonamid
dithiocarbam
moieti
introduc
biolog
activ
compar
unsubstitut
triazol
lascorb
acid
conjug
fig
evalu
impact
substitu
hydroxyethylen
conform
restrict
ethyliden
spacer
lacton
moieti
biolog
activ
two
seri
acid
deriv
synthes
outlin
scheme
isopropyliden
protect
group
subsequ
remov
lascorb
acid
afford
compound
perform
accord
procedur
describ
literatur
tosyl
group
compound
use
tosyl
chlorid
pyridin
afford
acid
deriv
compound
reaction
use
parent
molecul
synthesi
correspond
azido
deriv
acid
azido
deriv
synthes
reaction
monotosyl
deriv
sodium
azid
yield
introduc
posit
acid
via
copper
catalyz
huisgen
cycloaddit
cuaac
acid
correspond
termin
alkyn
method
scheme
yield
cu
ii
salt
presenc
reduc
agent
metal
copper
employ
gener
requir
cu
catalyst
situ
besid
divers
aliphat
aromat
substitu
benzenesulfonamid
dithiocarbam
recogn
import
pharmacophor
design
anticanc
agent
also
introduc
benzenesulfonamidebas
termin
alkyn
prepar
reaction
propargylamin
correspond
benzenesulfonyl
chlorid
tertbutyl
carbonothioyl
synthes
via
reaction
piperazin
carbon
disulfid
cs
propargyl
bromid
presenc
base
follow
method
scheme
best
yield
obtain
synthesi
compound
branch
side
chain
respect
optim
reaction
perform
use
anoth
synthet
pathway
scheme
method
b
method
b
repres
conveni
onepot
twostep
procedur
obtain
target
compound
situ
gener
azid
via
reaction
monotosyl
lascorb
acid
deriv
sodium
azid
follow
cuaac
reaction
azid
correspond
alkyn
afford
deriv
lascorb
acid
environment
reason
microwaveassist
reaction
perform
method
period
h
complet
reaction
howev
compar
yield
two
synthet
pathway
conclud
method
includ
isol
azido
deriv
gener
success
onepot
procedur
method
b
acid
deriv
contain
doubl
bond
prepar
start
ditosyl
compound
elimin
subsequ
nucleophil
substitut
nan
gave
azido
deriv
target
compound
obtain
click
reaction
azido
deriv
correspond
termin
alkyn
use
cu
oac
catalyt
cu
sourc
microflow
batch
condit
follow
previous
describ
procedur
vitro
antiprolif
evalu
silico
physicochem
profil
seri
acid
conjug
evalu
seven
human
tumor
cell
line
lung
adenocarcinoma
ductal
pancreat
adenocarcinoma
colorect
carcinoma
cervic
carcinoma
hela
hepatocellular
carcinoma
breast
adenocarcinoma
colorect
adenocarcinoma
metastat
cell
line
well
normal
skin
fibroblast
scheme
reagent
condit
acetyl
chlorid
aceton
ii
benzyl
chlorid
potassium
carbon
k
co
iii
acet
acid
methanol
iv
tosyl
chlorid
pyridin
dichloromethan
ch
cl
v
sodium
azid
nan
dimethylformamid
dmf
water
vi
cu
copper
ii
sulphat
cuso
tertbutanol
dmf
water
microwav
reactor
vii
nan
cu
cuso
dmf
water
microwav
reactor
viii
nan
acetonitril
ix
copper
ii
acet
cu
oac
methanol
hff
tabl
vari
substitu
posit
ring
librari
compound
creat
scheme
fig
structur
similar
aromat
aliphat
fragment
seri
recogn
wherea
introduct
sulfonamid
unit
format
doubl
bond
boost
highest
structur
diversif
fig
synthet
compound
span
wide
rang
lipophil
tabl
noctanolwat
partit
coeffici
clog
p
dibenzyl
deriv
within
rang
compound
doubl
bond
show
lipophil
analogu
addit
although
dibenzyl
deriv
quit
larg
molecul
molecular
weight
mw
rang
six
break
lipinski
rule
five
filter
druglik
molecul
tabl
supplementari
inform
gener
observ
acid
deriv
unsubstitut
ring
exhibit
cytostat
activ
evalu
tumor
cell
line
indic
natur
substitu
crucial
effect
antiprolif
activ
tabl
lasa
also
lack
cytostat
effect
among
lascorb
acid
deriv
contain
pbromophenyl
substitu
caus
strong
inhibitori
effect
tumor
cell
line
particularli
lung
adenocarcinoma
cell
electronwithdraw
trifluoromethylin
fluorosubstitut
aromat
moieti
small
influenc
antiprolif
effect
electrondon
methyl
group
caus
select
cytostat
activ
compound
strongli
inhibit
growth
lung
adenocarcinoma
ic
mm
hepatocellular
carcinoma
ic
mm
cell
line
longer
alkyl
substitu
phenyl
moieti
also
contribut
mark
albeit
nonspecif
cytostat
activ
contrari
pmethoxi
omethoxi
well
phydroxi
substitu
phenyl
respect
signific
impact
antiprolif
effect
tumor
cell
line
howev
pmethoxi
omethoxi
substitu
pronounc
cytotox
normal
fibroblast
hff
compound
long
straight
branch
respect
strong
effect
cytostat
activ
particularli
breast
adenocarcinoma
cell
line
thu
compound
exhibit
antitumor
activ
cell
nm
rang
ic
mm
ic
mm
howev
compound
also
cytotox
normal
fibroblast
ic
mm
show
nontox
ic
mm
among
compound
contain
sulfonamidesubstitut
moieti
pmethylphenyl
pchlorophenyl
moieti
acid
deriv
affect
mark
inhibitori
activ
cell
rang
mm
mm
compound
exert
also
strong
antiprolif
activ
cell
noteworthi
sulfonamidesubstitut
acid
deriv
exhibit
nonspecif
inhibitori
effect
high
cytotox
normal
fibroblast
hff
methylthiocarbothionyl
piperazin
acid
deriv
impact
antiprolif
activ
evalu
tumor
cell
line
relationship
lipophil
biolog
activ
acid
deriv
observ
suggest
compound
lowest
lipophil
properti
clogp
lack
antiprolif
activ
tumor
cell
lipophil
compound
clogp
clogp
show
cytostat
activ
tumor
cell
without
cytotox
normal
skin
fibroblast
replac
group
stereochem
constrain
doubl
bond
zconfigur
cytostat
effect
compound
seri
decreas
major
cancer
cell
line
tabl
howev
analogu
show
higher
cell
specif
best
activ
growth
cell
hela
deriv
femal
tumor
tabl
addit
aliphaticsubstitut
compound
exhibit
better
antiprolif
effect
compar
aromaticsubstitut
analogu
among
unsatur
acid
deriv
compound
di
trifluoromethyl
pbromo
pmethyl
substitu
respect
display
select
cytotox
effect
toward
cervic
carcinoma
cell
line
hela
tabl
besid
compound
cytotox
ic
mm
tumor
cell
line
normal
fibroblast
hff
acid
deriv
cyclopropyl
tertbutyl
side
chain
exert
strong
antiprolif
effect
ic
mm
ic
mm
breast
adenocarcinoma
cell
compound
exert
approxim
reduc
antiprolif
effect
cell
compar
satur
analogu
compound
exhibit
also
strong
cytostat
activ
cell
moder
cytotox
normal
fibroblast
within
seri
deriv
threefold
pronounc
inhibitori
activ
cell
satur
acid
analogu
opposit
acid
margin
antiprolif
effect
wherea
analogu
acid
seri
strong
antiprolif
effect
nm
rang
antiprolif
activ
synthet
compound
particularli
satur
deriv
seven
test
tumor
cell
line
mutual
quit
linearli
correl
illustr
pca
analysi
fig
linear
correl
coeffici
ic
valu
variou
pair
tumor
cell
line
compound
span
rang
median
coeffici
valu
greatest
similar
antiprolif
activ
observ
tumor
cell
line
hela
tabl
growth
inhibit
compound
tumor
cell
line
particularli
antiprolif
tumor
cell
line
lipophil
comparison
synthes
compound
two
seri
reveal
introduct
doubl
bond
increas
lipophil
compound
comparison
analogu
within
seri
compound
best
antiprolif
activ
clogp
valu
hydrophil
compound
within
seri
contain
side
chain
clogp
valu
show
low
moder
inhibitori
activ
compound
exhibit
clogp
show
appreci
antitumor
activ
overal
structureeact
relationship
append
acid
deriv
indic
type
substitu
scaffold
hydroxyethylen
ethyliden
spacer
connect
lacton
moieti
impact
antiprolif
activ
present
fig
tabl
growthinhibit
effect
vitro
lascorb
acid
compound
select
tumor
cell
line
normal
fibroblast
inhibitori
concentr
compound
concentr
requir
inhibit
tumor
cell
prolifer
na
activ
b
valu
clog
p
calcul
datawarrior
growthinhibit
effect
vitro
lascorb
acid
deriv
select
tumor
cell
line
normal
fibroblast
protein
target
compound
western
blot
analysi
due
excel
select
cytostat
activ
observ
breast
adenocarcinoma
cell
acid
chosen
evalu
mechan
action
vitro
mode
cell
death
induc
assess
annexin
v
assay
perform
describ
previous
tabl
obtain
result
show
induct
apoptosi
cell
treat
compound
compound
induc
moder
increas
earli
late
apoptot
cell
popul
h
respect
tabl
small
increas
necrot
cell
popul
also
observ
supplementari
inform
fig
sinc
breast
cancer
solid
tumor
long
known
hypox
crucial
involv
respons
mammalian
cell
hypoxia
recogn
suitabl
target
develop
antibreast
cancer
therapeut
besid
procarcinogen
effect
report
indic
stabil
breast
cancer
cell
decreas
cancer
cell
growth
promot
cell
cycl
arrest
autophagi
also
found
sever
cellular
respons
mediat
nitric
oxid
vice
versa
complex
relationship
cancer
thu
explor
tabl
coluor
denot
aromat
red
nonaromat
blue
charact
r
substitu
scheme
activ
compound
group
toward
left
side
plot
interpret
refer
color
figur
legend
reader
refer
web
version
articl
shown
biphas
respons
occur
regul
inde
initi
inhibit
hif
phd
activ
lead
accumul
cell
turn
result
increas
hif
phd
level
prevent
accumul
later
stage
breast
cancer
tissu
nitric
oxid
synthas
no
activ
higher
especi
highli
invas
tumor
accordingli
rel
express
analysi
hydroxyl
form
posit
protein
level
potenti
target
chosen
candid
structur
perform
fig
prolin
hydroxyl
known
lead
von
hippellindau
proteindepend
ubiquitin
rapid
proteasom
degrad
mean
measur
increas
level
form
indic
regul
level
tumor
cell
cell
treat
signific
increas
hydroxyl
level
along
decreas
level
observ
suggest
involv
regul
signal
pathway
accord
strong
growthinhibit
effect
acid
deriv
evalu
cmv
vzv
thymidin
kinas
defici
tk
thymidin
kinas
posit
tk
strain
vzv
herp
simplex
viru
type
vaccinia
viru
vesicular
stomat
viru
human
coronaviru
influenza
influenza
influenza
b
coxsacki
viru
reoviru
sindbi
viru
compound
exhibit
antivir
activ
present
tabl
activ
compar
ganciclovir
cidofovir
acyclovir
brivudin
comparison
antivir
activ
two
seri
compound
infer
conform
constrain
deriv
seri
show
better
antivir
potenti
cmv
similar
potenti
vzv
tabl
among
acid
deriv
exhibit
antivir
activ
compound
bear
respect
display
moder
antivir
potenc
cmv
davi
strain
acid
deriv
side
chain
antivir
activ
vzv
tk
best
valu
ec
mm
compound
howev
produc
alter
cellular
morpholog
concentr
somewhat
lower
compound
inhibit
viral
plaqu
format
mcc
mm
among
structur
analogu
observ
major
compound
show
appreci
antivir
activ
vaccinia
viru
vesicular
stomat
viru
human
coronaviru
influenza
influenza
influenza
b
coxsackieviru
reoviru
sindbi
viru
except
acid
deriv
exhibit
slight
activ
influenza
subtyp
supplementari
inform
tabl
acid
deriv
display
modest
activ
coronaviru
supplementari
inform
tabl
howev
compound
cytotox
normal
fibroblast
show
nontox
lipophil
compound
seri
clogp
within
seri
structur
analogu
potent
inhibitori
activ
cell
howev
exhibit
consider
reduc
antiprolif
activ
compar
analogu
detail
investig
mechan
action
select
candid
show
compound
induc
cell
death
breast
cancer
cell
partial
due
apoptosi
induct
moreov
shown
affect
signal
pathway
enhanc
express
hydroxyl
form
tag
degrad
concomitantli
decreas
express
addit
specif
antivir
effect
cmv
davi
observ
pmethoxyphenylsubstitut
deriv
activ
reduc
ec
mm
comparison
ganciclovir
moreov
compound
exhibit
antivir
potenti
vzv
ec
valu
similar
brivudin
howev
show
cytotox
concentr
close
antivir
activ
concentr
summari
find
encourag
develop
new
structur
relat
conform
unrestrict
lascorb
acid
analogu
target
signal
pathway
breast
cancer
therapi
also
addit
effort
devot
increas
anticmv
antivzv
potenc
andor
select
along
detail
investig
compound
mechan
antivir
action
may
differ
antivir
drug
ganciclovir
brivudin
unsatur
acid
deriv
synthes
accord
procedur
given
literatur
solut
acid
mg
dmf
ml
tertbutanol
ml
h
ml
cu
eq
cuso
solut
eq
correspond
alkyn
eq
ad
reaction
mixtur
heat
h
use
microwav
radiat
w
solvent
evapor
product
purifi
column
chromatographi
silica
gel
aluminium
oxid
obtain
oili
compound
tritur
use
nhexan
obtain
white
powder
solut
monotosyl
lascorb
acid
deriv
mg
dmf
ml
cu
eq
cuso
solut
eq
nan
eq
dissolv
h
ml
correspond
alkyn
eq
ad
reaction
mixtur
heat
h
use
microwav
radiat
w
solvent
evapor
product
purifi
column
chromatographi
silica
gel
aluminium
oxid
obtain
oili
compound
tritur
use
nhexan
obtain
white
powder
macc
fingerprint
gener
cluster
base
structur
similar
use
binari
tanimoto
distanc
similar
metric
well
principl
compon
analysi
pca
done
r
packag
rcdk
factoextra
princomp
respect
pca
analys
perform
term
measur
ic
valu
molecular
descriptor
simpl
structur
paramet
molecular
weight
mw
number
hydrogenbond
acceptingdon
atom
hbahbd
totalpolar
surfac
area
tsapsa
molecular
flexibl
low
high
shape
index
spheric
linear
number
rotabl
bond
ring
specif
aromat
ring
physicochem
properti
lipophil
clogp
aqueou
solubl
clog
calcul
algorithm
datawarrior
tabl
supplementari
inform
signific
group
pattern
term
molecular
descriptor
use
reveal
input
algorithm
smile
simplifi
molecularinput
lineentri
system
represent
compound
supplementari
inform
tabl
human
carcinoma
cell
line
hela
normal
fibroblast
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fb
uml
streptomycin
penicillin
mm
lglutamin
gibco
invitrogen
c
co
humidifi
atmospher
cell
line
obtain
american
type
cultur
collect
atcc
mtt
bromid
assay
perform
evalu
antiprolif
prolif
effect
tumor
normal
cell
line
tumor
cell
normal
cell
seed
microtit
plate
seed
densiti
cellswel
h
seed
cell
treat
freshli
prepar
compoundsdilut
five
concentr
mm
incub
h
solvent
dmso
test
eventu
cytotox
effect
concentr
neverexceed
mm
follow
h
cell
incub
compound
mtt
measur
perform
measur
absorb
treat
cell
transform
cell
percentag
growth
pg
use
formula
propos
nih
describ
previous
result
test
obtain
two
differ
experi
perfom
quadrupl
ic
valu
calcul
use
linear
regress
statist
analyz
anova
tukey
posthoc
test
p
program
cell
death
necrosi
induct
test
annexin
v
assay
briefli
x
cell
seed
onto
nunc
labtek
ii
chamber
slide
system
thermo
fischer
scientif
treat
compound
x
ic
mm
x
ic
mm
h
cell
stain
use
reagent
provid
annexinvfluo
stain
kit
roch
appli
scienc
accord
manufactur
recommend
cell
analyz
fluoresc
microscopi
zeiss
axio
observ
invert
phase
contrast
fluoresc
microscop
cell
count
condit
result
statist
analyz
anova
tukey
posthoc
test
p
cell
seed
petri
dish
x
cellsdish
treat
compound
ic
mm
h
compound
assess
effect
select
cell
low
ic
protein
lysat
prepar
use
buffer
contain
mm
tri
hcl
ph
mm
nacl
sodium
deoxychol
sd
proteas
phosphatas
inhibitor
cocktail
roch
switzerland
total
mg
protein
resolv
sd
polyacrylamid
gel
use
miniprotean
cell
biorad
usa
membran
incub
primari
antibodi
rabbit
mab
abcam
uk
mous
mab
santacruzbiotechnolog
usa
rabbit
mab
cell
signal
technolog
nl
c
overnight
secondari
antibodi
link
antimous
dako
usa
use
signal
visual
western
lightn
chemiluminesc
reagent
plu
kit
perkinelm
usa
imagequ
ge
healthcar
usa
atubulin
mous
mab
sigma
usa
use
load
control
signal
intens
particular
protein
line
blot
normal
intens
load
control
compar
quantiti
one
softwar
biorad
usa
valu
express
averag
sd
statist
analysi
perform
microsoft
excel
use
anova
p
antivir
activ
cmv
vzv
vaccinia
viru
vesicular
stomat
viru
vesicular
stomat
viru
human
coronaviru
influenza
influenza
influenza
b
coxsacki
viru
reoviru
sindbi
viru
determin
essenti
describ
previous
confluent
hel
fibroblast
grown
microtit
plate
infect
human
cmv
strain
davi
pfu
per
well
h
incub
period
residu
viru
remov
infect
cell
incub
medium
contain
differ
concentr
compound
test
duplic
incub
day
c
virusinduc
cytopathogen
monitor
microscop
ethanol
fixat
stain
giemsa
cmv
vzv
antivir
activ
express
ec
concentr
requir
reduc
virusinduc
cytopathogenici
ec
valu
calcul
graphic
plot
percentag
cytopathogen
function
concentr
compound
cytostat
measur
base
inhibit
hel
cell
growth
perform
follow
hel
cell
seed
rate
x
cellswel
microtit
plate
allow
prolifer
h
medium
contain
differ
concentr
test
compound
ad
day
incub
c
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
reduc
cell
growth
rel
number
cell
untreat
control
cc
valu
estim
graphic
plot
number
cell
percentag
control
function
concentr
test
compound
cytotox
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
confluent
cell
cultur
expos
compound
author
declar
conflict
interest
